GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » Asset Impairment Charge

Innovita Biological Technology Co (SHSE:688253) Asset Impairment Charge : ¥0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co Asset Impairment Charge?

Innovita Biological Technology Co's Asset Impairment Charge for the three months ended in Sep. 2024 was ¥0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.0 Mil.


Innovita Biological Technology Co Asset Impairment Charge Historical Data

The historical data trend for Innovita Biological Technology Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co Asset Impairment Charge Chart

Innovita Biological Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial - - - - -

Innovita Biological Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Innovita Biological Technology Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


Innovita Biological Technology Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovita Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Executives
Chen Fu Kang senior management
Zhang Xiao Gang Directors, senior managers
Zhang Xiu Jie Directors, senior managers
Chen Ting You Director, core technical staff
Wang Heng Qiang Core technical personnel
Zhao Xiu Juan Directors, senior managers
Ding Zhi Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines